Registro:

Referencias:

• Fuqua, S.A., Fitzgerald, S.D., Allred, D.C., Elledge, R.M., Nawaz, Z., McDonnell, D.P., O'Malley, B.W., McGuire, W.L., Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors (1992) Cancer Res, 52, pp. 483-486
• Wiebe, V.J., Osborne, C.K., McGuire, W.L., Degregorio, M.W., Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors (1992) J Clin Oncol, 10, pp. 990-994
• Santen, R., Jeng, M.H., Wang, J.P., Song, R., Masamura, S., McPherson, R., Santner, S., Shim, W.S., Adaptive hypersensitivity to estradiol: Potential mechanism for secondary hormonal responses in breast cancer patients (2001) J Steroid Biochem Mol Biol, 79, pp. 115-125
• Osborne, C.K., Bardou, V., Hopp, T.A., Chamness, G.C., Hilsenbeck, S.G., Fuqua, S.A., Wong, J., Schiff, R., Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer (2003) J Natl Cancer Inst, 95, pp. 353-361
• Aronica, S.M., Katzenellenbogen, B.S., Progesterone receptor regulation in uterine cells: Stimulation by estrogen, cyclic adenosine 3′, 5′- monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors (1991) Endocrinology, 128, pp. 2045-2052
• Osborne, C.K., Schiff, R., Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer (2003) Breast, 12, pp. 362-367
• Shou, J., Massarweh, S., Osborne, C.K., Wakeling, A.E., Ali, S., Weiss, H., Schiff, R., Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer (2004) J Natl Cancer Inst, 96, pp. 926-935
• Sandberg, A.A., Turc-Carel, C., The cytogenetics of solid tumors: Relation to diagnosis, classification and pathology (1987) Cancer, 59, pp. 387-395
• Greaves, M.F., Biological models for leukaemia and lymphoma (2004) IARC Sci Publ, pp. 351-372
• Dutrillaux, B., Gerbault-Seureau, M., Remvikos, Y., Zafrani, B., Prieur, M., Breast cancer genetic evolution: I. Data from cytogenetics and DNA content (1991) Breast Cancer Res Treat, 19, pp. 245-255
• Pandis, N., Jin, Y., Gorunova, L., Petersson, C., Bardi, G., Idvall, I., Johansson, B., Mitelman, F., Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups (1995) Genes Chromosomes Cancer, 12, pp. 173-185
• Steinarsdottir, M., Petursdottir, I., Snorradottir, S., Eyfjord, J.E., Ogmundsdottir, H.M., Cytogenetic studies of breast carcinomas: Different karyotypic profiles detected by direct harvesting and short-term culture (1995) Genes Chromosomes Cancer, 13, pp. 239-248
• Tirkkonen, M., Tanner, M., Karhu, R., Kallioniemi, A., Isola, J., Kallioniemi, O.P., Molecular cytogenetics of primary breast cancer by CGH (1998) Genes Chromosomes Cancer, 21, pp. 177-184
• Chang, J., Powles, T.J., Allred, D.C., Ashley, S.E., Makris, A., Gregory, R.K., Osborne, C.K., Dowsett, M., Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients (2000) Clin Cancer Res, 6, pp. 616-621
• O'Reilly, S.M., Camplejohn, R.S., Rubens, R.D., Richards, M.A., DNA flow cytometry and response to preoperative chemotherapy for primary breast cancer (1992) Eur J Cancer, 28, pp. 681-683
• Lanari, C., Molinolo, A.A., Pasqualini, C.D., Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice (1986) Cancer Lett, 33, pp. 215-223
• Molinolo, A.A., Lanari, C., Charreau, E.H., Sanjuan, N., Pasqualini, C.D., Mouse mammary tumors induced by medroxyprogesterone acetate: Immunohistochemistry and hormonal receptors (1987) J Natl Cancer Inst, 79, pp. 1341-1350
• Lamb, C., Simian, M., Molinolo, A., Pazos, P., Lanari, C., Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: Progesterone receptor involvement in serum or growth factor-induced cell proliferation (1999) J Steroid Biochem Mol Biol, 70, pp. 133-142
• Kordon, E., Lanari, C., Meiss, R., Charreau, E., Pasqualini, C.D., Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate (1990) Breast Cancer Res Treat, 17, pp. 33-43
• Kordon, E.C., Guerra, F., Molinolo, A.A., Charreau, E.H., Pasqualini, C.D., Pazos, P., Dran, G., Lanari, C., Effect of sialoadenectomy on medroxyprogesterone-acetate-induced mammary carcinogenesis in BALB/c mice: Correlation between histology and epidermal-growth-factor receptor content (1994) Int J Cancer, 59, pp. 196-203
• Helguero, L.A., Viegas, M., Asaithamby, A., Shyamala, G., Lanari, C., Molinolo, A.A., Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment (2003) Breast Cancer Res Treat, 79, pp. 379-390
• Lanari, C., Kordon, E., Molinolo, A., Pasqualini, C.D., Charreau, E.H., Mammary adenocarcinomas induced by medroxyprogesterone acetate: Hormone dependence and EGF receptors of BALB/c in vivo sublines (1989) Int J Cancer, 43, pp. 845-850
• Pandis, N., Heim, S., Bardi, G., Limon, J., Mandahl, N., Mitelman, F., Improved technique for short-term culture and cytogenetic analysis of human breast cancer (1992) Genes Chromosomes Cancer, 5, pp. 14-20
• Dran, G., Luthy, I.A., Molinolo, A.A., Charreau, E.H., Pasqualini, C.D., Lanari, C., Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma (1995) Breast Cancer Res Treat, 35, pp. 173-186
• Seabright, M., A rapid banding technique for human chromosomes (1971) Lancet, 2, pp. 971-972
• Shen, J., Bao, Y., Liu, H.M., Lee, P., Leonard, J.V., Chen, Y.T., Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle (1996) J Clin Invest, 98, pp. 352-357
• Fabris, V., Lamb, C.A., Keck, C., Aldaz, M.C., Merani, S., Lanari, C., Karyotypic evolution of four novel mouse mammary carcinoma cell lines: Identification of marker chromosomes by fluorescence in situ hybridization (2003) Cancer Genet Cytogenet, 142, pp. 36-45
• Efeyan, A., Fabris, V., Merani, S., Lanari, C., Molinolo, A.A., Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor (2004) Breast Cancer Res Treat, 83, pp. 233-244
• Donehower, L.A., Godley, L.A., Aldaz, C.M., Pyle, R., Shi, Y.P., Pinkel, D., Gray, J., Varmus, H.E., The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model (1996) Prog Clin Biol Res, 395, pp. 1-11
• Li, J.J., Papa, D., Davis, M.F., Weroha, S.J., Aldaz, C.M., El Bayoumy, K., Ballenger, J., Li, S.A., Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: Comparison to invasive human ductal breast cancer (2002) Mol Carcinog, 33, pp. 56-65
• Le Roy, H., Ricoul, M., Ogata, H., Apiou, F., Dutrillaux, B., Chromosome anomalies in mammary carcinoma from transgenic WAPRAS mice: Comparison with human data (1993) Genes Chromosomes Cancer, 6, pp. 156-160
• Montagna, C., Andrechek, E.R., Padilla-Nash, H., Muller, W.J., Ried, T., Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu (2002) Oncogene, 21, pp. 890-898
• Weaver, Z.A., McCormack, S.J., Liyanage, M., Du Manoir, S., Coleman, A., Schrock, E., Dickson, R.B., Ried, T., A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice (1999) Genes Chromosomes Cancer, 25, pp. 251-260
• Pati, D., Haddad, B.R., Haegele, A., Thompson, H., Kittrell, F.S., Shepard, A., Montagna, C., Medina, D., Hormone-induced chromosomal instability in p53-null mammary epithelium (2004) Cancer Res, 64, pp. 5608-5616
• Katayama, H., Brinkley, W.R., Sen, S., The Aurora kinases: Role in cell transformation and tumorigenesis (2003) Cancer Metastasis Rev, 22, pp. 451-464
• Goepfert, T.M., McCarthy, M., Kittrell, F.S., Stephens, C., Ullrich, R.L., Brinkley, B.R., Medina, D., Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells (2000) FASEB J, 14, pp. 2221-2229
• Medina, D., Kittrell, F.S., Shepard, A., Contreras, A., Rosen, J.M., Lydon, J., Hormone dependence in premalignant mammary progression (2003) Cancer Res, 63, pp. 1067-1072
• Balana, M.E., Lupu, R., Labriola, L., Charreau, E.H., Elizalde, P.V., Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas (1999) Oncogene, 18, pp. 6370-6379
• Montecchia, M.F., Lamb, C., Molinolo, A.A., Luthy, I.A., Pazos, P., Charreau, E., Vanzulli, S., Lanari, C., Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas (1999) J Steroid Biochem Mol Biol, 68, pp. 11-21
• Lanari, C., Montecchia, M.F., Pazos, P., Simian, M., Vanzulli, S., Lamb, C., Molinolo, A.A., Progestin-induced mammary adenocarcinomas in BALB/c mice: Progression from hormone-dependent to autonomous tumors (1997) Medicina (B Aires), 57, pp. 55-69
• Wang, X., Jin, D.Y., Ng, R.W., Feng, H., Wong, Y.C., Cheung, A.L., Tsao, S.W., Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells (2002) Cancer Res, 62, pp. 1662-1668
• Warner, S.L., Bearss, D.J., Han, H., Von Hoff, D.D., Targeting Aurora-2 kinase in cancer (2003) Mol Cancer Ther, 2, pp. 589-595
• Aldaz, C.M., Liao, Q.Y., Paladugu, A., Rehm, S., Wang, H., Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: High frequency of chromosome 4 loss of heterozygosity at advanced stages of progression (1996) Mol Carcinog, 17, pp. 126-133
• Cool, M., Jolicoeur, P., Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice (1999) Cancer Res, 59, pp. 2438-2444
• Radany, E.H., Hong, K., Kesharvarzi, S., Lander, E.S., Bishop, J.M., Mouse mammary tumor virus/v-Ha-ras transgene-induced mammary tumors exhibit strain-specific allelic loss on mouse chromosome 4 (1997) Proc Natl Acad Sci U S a, 94, pp. 8664-8669
• Bieche, I., Khodja, A., Lidereau, R., Deletion mapping of chromosomal region 1p32-pter in primary breast cancer (1999) Genes Chromosomes Cancer, 24, pp. 255-263
• Larramendy, M.L., Lushnikova, T., Bjorkqvist, A.M., Wistuba, I.I., Virmani, A.K., Shivapurkar, N., Gazdar, A.F., Knuutila, S., Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines (2000) Cancer Genet Cytogenet, 119, pp. 132-138

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------